v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 1,338
Restricted cash 202  
Trade receivables 257 111
Other accounts receivable and prepaid expenses 158 268
Inventory 148 121
Total current assets 765 1,838
Non-current assets:    
Fixed assets, net 3 4
Other assets 32
Severance pay fund 209 194
Total non-current assets 244 198
Total assets 1,009 2,036
Current liabilities:    
Trade payables 136 129
Other accounts payable and accrued expenses 189 280
Common stock payable 844
Notes payable to a related party, net of discount of $123 77
Notes payable, current 4
Total current liabilities 1,250 409
Non-current liabilities:    
Accrued severance pay 279 279
Deferred licensing income 226
Notes payable, non-current 38
Total liabilities 1,793 688
Commitments and contingencies (Note 10)
Stockholders' equity:    
Common stock of $0.001 par value - Authorized: 20,000,000 shares at June 30, 2020 and December 31, 2019; Issued and outstanding: 4,313,764 and 4,203,764 shares at June 30, 2020 and December 31, 2019, respectively 5 5
Additional paid in capital 39,935 39,669
Accumulated deficit (40,728) (38,330)
Total stockholders' equity (784) 1,348
Total liabilities and stockholders' equity 1,009 2,036
Series C Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock value 2 2
Total stockholders' equity 2 2
Series D Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock value
Total stockholders' equity
Series E Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock value 2 2
Total stockholders' equity $ 2 $ 2

Source